Many other members of Big Pharma spent more on dividends and stock buybacks, a strategy some view as shortsighted Continue reading...
from Yahoo Finance https://ift.tt/3aDiiAQ
Thursday, January 23, 2020
Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments
About Gulf
Author Description here.. Nulla sagittis convallis. Curabitur consequat. Quisque metus enim, venenatis fermentum, mollis in, porta et, nibh. Duis vulputate elit in elit. Mauris dictum libero id justo.
No comments:
Write comments